ITGen scientist operating a detection instrument
Home / Capabilities / R&D

Research & Development

From antigen design to validated assays — the science behind every ITGen test.

Our R&D

A dedicated team turning biology into answers.

Our R&D team develops the critical raw materials and assays behind our products — recombinant antigens, antibodies and reaction systems — and carries them through validation, registration and transfer to production.

Recombinant proteins
Platform 01

Recombinant proteins

Genetic engineering and protein expression give our tests their specificity.

  • Antigen design & expression
  • Antibody screening
  • Raw material quality control
Lateral flow
Platform 02

Lateral flow

Immunochromatographic rapid tests with clear visual results in minutes, at the point of care.

  • Colloidal gold & fluorescence formats
  • Single and multi-panel cassettes
  • Whole blood, serum and plasma samples
Molecular POCT
Platform 03

Molecular POCT

Point-of-care nucleic-acid detection that brings lab-grade sensitivity closer to the patient.

  • Isothermal and fluorescence PCR
  • Pet PCR and microfluidic analysers
  • Sample-to-answer workflows
ELISA
Platform 04

ELISA

Enzyme-linked immunoassays for laboratory screening and disease-control programmes.

  • Antibody and antigen ELISA kits
  • High-throughput screening
  • Livestock disease surveillance
How we develop

From idea to approved product.

Needs

Clinical and market requirements from vets and partners.

Materials

Antigen and antibody development.

Assay

Method development and optimisation.

Validation

Performance evaluation and stability.

Registration

Dossiers, approvals and transfer to production.

Intellectual property

50+ granted patents.

View all certificates →
ITGen headquarters, Hangzhou

Let's talk.

ITGen headquarters · Hangzhou, China

contact@itgen.com→WhatsApp →